| |||||||||||||||||
Number 29 CRITICAL LIMB ISCHEMIA SUCCESSFULLY TREATED BY INTERMITTENT PNEUMATIC COMPRESSION Yoram Moses MD and Boris Yoffe MD, FACS Intermittent pneumatic compression is a well-known method for the prevention of deep vein thrombosis and reduction of lymphedema in the lower limbs. Recently however, the concept of using IPC for the treatment of ischemic legs reemerged [1]. This method, which applies impulse compression based on high pressure rapid inflation technology, was found to improve arterial ciritical in the loer limbs [2]. We present the case of patient with critical limb ischemia successfully treated by thi method. Patient Description After team consult the patient was considered to be a non-surgical candidate because of the high operative risk. We decided to try the recently introduced IPC device ArtAssist AA-1000e (ACI Medical, In. San Marcos, CA, USA) that has food and calf cuffs (known as IPFCC). A treatment regimen of 3 hours a day in divided sessions was started immediately and the patient continued this mode of therapy for 3 months as an outpatient. We noticed a prominent reduction in his leg edema after 3 days, and the patient felt relief of his rest pain. Three weeks after the treatment was begun the hlcers had healed. Doppler examinations at the end of the 3 months demonstrated a significantly improved ankle-brachial index in both legs compared to the previous Doppler exm [figure], and there was a favorable change in the pulse volume recording. At the end of 3 motnhs there was a subjective and objective improvement in both legs. We were not able to detect any change in the distance walking because the patient's severe COPD prevented prolonged ambulation. | |||||||||||||||||
Comment It is well known that edema itself is harmful to the tissue perfusion and that reduction of the edema by compression with the other mechanisms mentioned contributes to better vascularization. This kind of technique simulates brisk walking and exercise and finally induces collateral formation. Although there is some knowledge on the long-term effect of IPC on arteriopathy, its precise role in the management of peripheral occlusive arterial disease has not yet been determined. References
Correspondence: Dr. B. Yoffe, Head, Dept. of General and Vascular Surgery, Barzilai Medical Center, Ashkelon 78306, Israel. E-mail: sarel@barzi.health.gov.il | |||||||||||||||||
| |||||||||||||||||